These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 35205356)

  • 1. Pharmacogenetics of Drugs Used in the Treatment of Cancers.
    Franczyk B; Rysz J; Gluba-Brzózka A
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.
    Bosch TM
    Methods Mol Biol; 2008; 448():63-76. PubMed ID: 18370231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics for individualized cancer chemotherapy.
    Efferth T; Volm M
    Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M; Yokoi T
    Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: road to anticancer therapeutics nirvana?
    Desai AA; Innocenti F; Ratain MJ
    Oncogene; 2003 Sep; 22(42):6621-8. PubMed ID: 14528287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer pharmacogenomics: international trends.
    Yamayoshi Y; Iida E; Tanigawara Y
    Int J Clin Oncol; 2005 Feb; 10(1):5-13. PubMed ID: 15729594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics in cancer treatment.
    Nagasubramanian R; Innocenti F; Ratain MJ
    Annu Rev Med; 2003; 54():437-52. PubMed ID: 12525681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics of cancer chemotherapy-induced toxicity.
    Miller CR; McLeod HL
    J Support Oncol; 2007 Jan; 5(1):9-14. PubMed ID: 17265780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [SNPs associated with adverse effects].
    Isomura M; Miki Y
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1908-13. PubMed ID: 16282725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacogenetics in oncology].
    Morán González D; Jiménez Cabrera S; Domínguez-Gil Hurlé A
    Med Clin (Barc); 2008 Jul; 131(5):184-95. PubMed ID: 18674490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
    Bertholee D; Maring JG; van Kuilenburg AB
    Clin Pharmacokinet; 2017 Apr; 56(4):317-337. PubMed ID: 27641154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.
    Moradi-Marjaneh R; Khazaei M; Seifi S; Hassanian SM; Ferns GA; Avan A
    Curr Pharm Des; 2018; 24(23):2710-2718. PubMed ID: 30051785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of cancer drugs.
    Hertz DL; Rae J
    Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomic progress in individualized dosing of key drugs for cancer patients.
    Walko CM; McLeod H
    Nat Clin Pract Oncol; 2009 Mar; 6(3):153-62. PubMed ID: 19174777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Genetic Polymorphisms in Drug-Metabolizing Enzyme-Mediated Toxicity and Pharmacokinetic Resistance to Anti-Cancer Agents: A Review on the Pharmacogenomics Aspect.
    Narendra G; Choudhary S; Raju B; Verma H; Silakari O
    Clin Pharmacokinet; 2022 Nov; 61(11):1495-1517. PubMed ID: 36180817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model.
    Goetz MP; Ames MM; Weinshilboum RM
    Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.